SBI Securities’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4 Sell
1
-1
-50% -$7 ﹤0.01% 4001
2026
Q1
$18 Hold
2
﹤0.01% 3780
2025
Q4
$23 Hold
2
﹤0.01% 3747
2025
Q3
$49 Hold
2
﹤0.01% 3719
2025
Q2
$33 Sell
2
-13
-87% -$224 ﹤0.01% 3805
2025
Q1
$271 Buy
15
+11
+275% +$314 ﹤0.01% 3109
2024
Q4
$145 Buy
+4
New +$153 ﹤0.01% 3349

Other funds holding CDLX

SBI Securities's CDLX Position: Q2 2026 in Review

SBI Securities reduced its Cardlytics (CDLX) stake by 50% in Q2 2026, selling an estimated $7 and leaving 1 share worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #4001.

SBI Securities first reported a position in CDLX in Q4 2024 and has held it in 7 quarters since. The position peaked at $271 in Q1 2025. 42 funds tracked by Wall St. Rank hold CDLX as of Q2 2026.

  • SBI Securities held 1 share of Cardlytics worth $4 as of Q2 2026.
  • SBI Securities sold 1 Cardlytics share in Q2 2026, an estimated $7.
  • Cardlytics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #4001 holding.
  • SBI Securities first reported a position in Cardlytics in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Cardlytics position peaked at $271 in Q1 2025.
  • 42 funds tracked by Wall St. Rank held Cardlytics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.